The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
November 21st 2024
Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
MR exhibitors focus on elastography, innovative design
March 8th 2010Physicians have used palpation regularly as a diagnostic technique since the days of the ancient Greeks. Up to now, the potential value of this method has been explored in the imaging field only by ultrasound research teams, but at this year’s ECR technical exhibition, delegates can see for themselves how the same principles may be combined with MRI to improve diagnosis in patients with liver disease.
Diffusion-weighted MR looks to add new biomarker for oncologic imaging
March 5th 2010MR developments over recent years have allowed researchers to explore water molecule motion between cells using diffusion-weighted imaging to indirectly measure cellular density within a tissue. This has provided a new and continuously evolving tool in oncologic imaging for lesion detection, characterisation, and therapy assessment.
Breast imagers offer tips for getting reluctant patients to come in for breast MRI
February 11th 2010As Diagnostic Imaging previously mentioned, most women at high risk for breast cancer come in for their breast MRI. However, claustrophobia and reluctant patients still exist. Below breast imagers offer their tips.
European campaign seeks to confront threat to MRI
January 28th 2010Recently, thousands of European radiologists have received an e-mail with this rather alarmist heading: “EU directive still threatens MRI.” Another e-mail doing the rounds has an equally sensational title: “No more MRI in Europe?”
Serious long-term side effects dog hepatopancreatic HIFU
December 7th 2009Though generally deemed safe, high-intensity focused-ultrasound ablation of liver and pancreas cancers can lead to delayed complications. According to Korean researchers, practitioners should be aware of-and watch closely for-local and systemic post-HIFU side effects several years down the road.
Bone marrow lesions, female sex, predict knee osteoarthritis progression
December 4th 2009Knee osteoarthritis progression can be predicted by MRI findings of medial collateral ligament edema, bone marrow lesions, and being female, according to a study presented at the RSNA meeting Thursday morning.
Toshiba unveils wide-bore 3T MR scanner
December 4th 2009Toshiba laid the groundwork for entering the 3T marketplace in the U.S. with the unveiling of its Vantage Titan 3T system at RSNA 2009. The work-in-progress, which is pending FDA clearance, leapfrogs earlier generations of 3T scanners with a 71-cm tapered aperture and Pianissimo noise reduction technology.
Multimodality breast cancer screening shows possible boon for high-risk women
December 4th 2009Breast cancer detection rates increase substantially when women at high risk and those with dense breasts undergo mammography and ultrasound annually, according to a study presented Wednesday at the 2009 RSNA meeting. MRI is an even more effective technique when used with mammography, but only for women who are at high risk for the condition.
Advanced MRI reveals damage in brains of retired NFL football players
December 3rd 2009The brains of 16 retired National Football League players with known cognitive impairment show signs of damaging atrophy, according to advanced MRI studies described Wednesday at the 2009 RSNA annual meeting.
GE brings its first wide-bore 1.5T MR scanner to RSNA 2009
December 3rd 2009A high-field, wide-bore MR scanner from GE Healthcare is making its first appearance at an RSNA meeting. The system, called Optima MR450w, was officially unveiled some three months ago, but RSNA 2009 is its first major trade show.
Breast MRI assesses tumor size the best prior to surgery, post-treatment
December 2nd 2009MRI is the best method to assess breast cancer tumor size prior to surgery and after chemotherapy, according to findings from the American College of Radiology Imaging Network trial 6657. Size on mammography does not correlate with true residual disease in patients treated with neoadjuvant chemotherapy and thus MRI is the best modality, the researchers said.
Manganese liver contrast medium may help to cut imaging times
December 1st 2009CMC-001, an investigational MRI liver contrast medium, may be at least a partial answer to reducing the long imaging times that have frustrated patients and encouraged radiologists to look for imaging alternatives to aid diagnosis of hepatocellular carcinoma and colon cancer metastases in the liver. A phase III trial indicates it is as sensitive as a gadolinium-enhanced MRI for detecting colon cancer metastases, but at the cost of lower specificity.
Siemens unveils wide-bore MR scanners at RSNA 2009
December 1st 2009Siemens brought two blockbuster MR offerings to the RSNA meeting this week: the 3T Skyra and 1.5T Aera. The two new products, works-in-progress pending FDA clearance but scheduled to begin shipping by mid-2010, promise a productivity lift through their patient-friendly bores, measuring 70 cm wide, and automation that simplifies complex scan tasks.
Siemens IT platform promises boost in MR, CT productivity
December 1st 2009Siemens unveiled a new information technology at RSNA 2009: software that promises to do the tedious and time-consuming tasks involved in reading MR and CT exams. The new product, a work-in-progress pending FDA clearance, is an outgrowth of the syngo platform that Siemens has used for years to provide consistency in data processing among its modalities.
Digital mammo plus breast MRI proves clinically beneficial, but not cost-effective
December 1st 2009Digital mammography plus MRI is the most clinically effective strategy for screening women carrying a genetic mutation known to increase the risk for breast cancer. However, unless the cost of breast MRI decreases substantially, the modality doesn’t translate as cost-effective, according to a study presented on Tuesday at the RSNA 2009 meeting.